BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced application of ...
BD (Becton, Dickinson and Company) announced European CE Mark approval for the Liverty transjugular intrahepatic portosystemic sh ...
Franklin Lakes, New Jersey-based BD designed the stent graft to expand treatment options for patients with cirrhosis and ...
Zacks Investment Research on MSN
BD Files for CE Mark of Liverty TIPS Stent for Portal Hypertension
Becton, Dickinson and Company BDX, popularly known as BD, recently announced that it has applied for CE Mark approval for its ...
Becton Dickinson (NYSE:BDX) advanced its Liverty TIPS Stent Graft for portal hypertension toward EU approval, supported by ...
Designed to expand treatment options for patients with cirrhosis and complications of portal hypertension, this ...
Transjugular intrahepatic portosystemic shunts (TIPS) are implanted in patients with liver cirrhosis to reduce portal pressure. Indications for TIPS use include uncontrolled variceal bleeding or ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results